Ghada Miremont-Salamé

Implementation of an automated signal detection method in the French pharmacovigilance database: a feasibility study

Ismaïl Ahmed, Véronique Pizzoglio, Pascal Auriche, 2011, European Journal of Clinical Pharmacology.

Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting

Ismaïl Ahmed, Frantz Thiessard, Annie Fourrier-Réglat, 2009, Statistics in medicine.

Drug interactions between inhaled corticosteroids and enzymatic inhibitors

Nicholas Moore, Françoise Haramburu, Ghada Miremont-Salamé, 2009, European Journal of Clinical Pharmacology.

Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.

Nicholas Moore, Annie Fourrier-Réglat, Bernard Bégaud, 2007, British journal of clinical pharmacology.

Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).

Françoise Haramburu, Ghada Miremont-Salamé, Michel Mallaret, 2014, Therapie.

Trends in Spontaneous Adverse Drug Reaction Reports to the French Pharmacovigilance System (1986—2001)

Frantz Thiessard, Annie Fourrier-Réglat, Pascale Tubert-Bitter, 2005, Drug safety.

A potential competition bias in the detection of safety signals from spontaneous reporting databases

Nicholas Moore, Antoine Pariente, Paul Avillach, 2010, Pharmacoepidemiology and drug safety.

Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study

Françoise Haramburu, Ghada Miremont-Salamé, Pernelle Noize, 2015, Fundamental & clinical pharmacology.

Differences between clinical trials and postmarketing use.

Nicholas Moore, Bernard Bégaud, Ghada Miremont-Salamé, 2003, British journal of clinical pharmacology.